biostudies-literatureCrystal SNCATS NIH HHSNIDA NIH HHS109269https://www.ebi.ac.uk/biostudies/studies/S-EPMC8943804biostudies-literatureUnknown232<h4>Background</h4>Patients with medically-treated opioid overdose are at high risk for subsequent adverse outcomes, including repeat overdose. Understanding factors associated with repeat overdose can aid in optimizing post-overdose interventions.<h4>Methods</h4>We conducted a longitudinal, retrospective cohort study using NJ Medicaid data from 2014 to 2019. Medicaid beneficiaries aged 12-64 with an index opioid overdose from 2015 to 2018 were followed for one year for subsequent overdose. Exposures included patient demographics; co-occurring medical, mental health, and substance use disorders; service and medication use in the 180 days preceding the index overdose; and MOUD following index overdose.<h4>Results</h4>Of 4898 individuals meeting inclusion criteria, 19.6% had repeat opioid ovDrug and alcohol dependenceOpioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.PMC8943804UL1 TR003017R01 DA047347K23 DA044342K01 DA049950Nowels MOlfson MCrystal SSamples HTreitler PWilliams ARfalseOpioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.<h4>Background</h4>Patients with medically-treated opioid overdose are at high risk for subsequent adverse outcomes, including repeat overdose. Understanding factors associated with repeat overdose can aid in optimizing post-overdose interventions.<h4>Methods</h4>We conducted a longitudinal, retrospective cohort study using NJ Medicaid data from 2014 to 2019. Medicaid beneficiaries aged 12-64 with an index opioid overdose from 2015 to 2018 were followed for one year for subsequent overdose. Exposures included patient demographics; co-occurring medical, mental health, and substance use disorders; service and medication use in the 180 days preceding the index overdose; and MOUD following index overdose.<h4>Results</h4>Of 4898 individuals meeting inclusion criteria, 19.6% had repeat opioid ov2022-01-01T00:00:00Z2022 Mar2025-04-04T21:43:50.953Z2025-04-04T21:43:50.953ZS-EPMC89438043503860910.1016/j.drugalcdep.2022.109269